[go: up one dir, main page]

MXPA02009643A - Sintesis acortada de derivados de 3,3-diarilpropilamina. - Google Patents

Sintesis acortada de derivados de 3,3-diarilpropilamina.

Info

Publication number
MXPA02009643A
MXPA02009643A MXPA02009643A MXPA02009643A MXPA02009643A MX PA02009643 A MXPA02009643 A MX PA02009643A MX PA02009643 A MXPA02009643 A MX PA02009643A MX PA02009643 A MXPA02009643 A MX PA02009643A MX PA02009643 A MXPA02009643 A MX PA02009643A
Authority
MX
Mexico
Prior art keywords
derivatives
shortened synthesis
diarylpropylamine
diarylpropylamine derivatives
shortened
Prior art date
Application number
MXPA02009643A
Other languages
English (en)
Inventor
Claus Meese
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Publication of MXPA02009643A publication Critical patent/MXPA02009643A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/16—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/20—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 hydrogenated in the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/66—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with quaternised amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C07D453/04—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invencion se refiere a un metodo para producir derivados de 3,3-diarilpropilamjnas de la formula general (I) y productos intermedios estables, altamente de manera esterica puros y a su uso para la produccion de composiciones farmaceuticas.
MXPA02009643A 2000-06-14 2001-06-11 Sintesis acortada de derivados de 3,3-diarilpropilamina. MXPA02009643A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10028443A DE10028443C1 (de) 2000-06-14 2000-06-14 Verfahren zur Herstellung von 3,3-Diarylpropylaminen, (R,S)- und (R)-4-Phenyl-2-chromanon-6-carbonsäure sowie (R)-4-Phenyl-2-chromanon-carbonsäure-cinchonidinsalz und deren Verwendung zur Herstellung eines rechtsdrehenden Hydroxybenzylalkohols und von pharmazeutischen Zusammensetzungen
PCT/EP2001/006577 WO2001096279A1 (de) 2000-06-14 2001-06-11 Verkürzte synthese von 3,3-diarylpropylamin-derivaten

Publications (1)

Publication Number Publication Date
MXPA02009643A true MXPA02009643A (es) 2003-03-10

Family

ID=7645152

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02009643A MXPA02009643A (es) 2000-06-14 2001-06-11 Sintesis acortada de derivados de 3,3-diarilpropilamina.

Country Status (23)

Country Link
US (1) US6809214B2 (es)
EP (1) EP1289929B1 (es)
JP (2) JP4002180B2 (es)
KR (1) KR100580568B1 (es)
CN (1) CN1234679C (es)
AT (1) ATE368640T1 (es)
AU (2) AU6906301A (es)
BR (1) BR0111266A (es)
CA (1) CA2412047C (es)
CZ (1) CZ20023665A3 (es)
DE (2) DE10028443C1 (es)
ES (1) ES2290153T3 (es)
HU (1) HUP0204563A3 (es)
IL (2) IL151595A0 (es)
IS (1) IS6534A (es)
MX (1) MXPA02009643A (es)
NO (1) NO20025967L (es)
NZ (1) NZ521265A (es)
PL (1) PL360845A1 (es)
RU (1) RU2270188C2 (es)
SK (1) SK142003A3 (es)
WO (1) WO2001096279A1 (es)
ZA (1) ZA200207204B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957073A1 (en) 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
WO2005012227A2 (en) * 2003-08-05 2005-02-10 Ranbaxy Laboratories Limited Process for preparation of 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethyl-phenol, a metabolite of tolterodine
JP4513535B2 (ja) * 2004-12-03 2010-07-28 住友化学株式会社 トルテロジンの製造方法
WO2006074478A1 (en) * 2005-01-10 2006-07-13 Teva Pharmaceuticals Usa, Inc. Substantially pure tolterodine tartrate and process for preparing thereof
CA2647398C (en) * 2006-05-31 2013-07-30 Schwarz Pharma Ltd. New synthesis of substituted hydroxymethyl phenols
KR101488740B1 (ko) 2006-06-12 2015-02-03 유씨비 파마 게엠베하 새로운 키랄 중간체, 그 키랄 중간체의 제조방법 및 톨테로딘, 페소테로딘 또는 그 활성대사물질의 제조에서 그키랄 중간체의 사용
SI2281801T1 (sl) * 2009-07-27 2014-04-30 Crystal Pharma, S.A.U. Postopek za pridobivanje 3,3-diphenilpropilamina
IT1396373B1 (it) * 2009-10-29 2012-11-19 Dipharma Francis Srl Procedimento per la preparazione di fesoterodina.
EP2364966A1 (en) 2010-03-09 2011-09-14 LEK Pharmaceuticals d.d. Process for preparation of 3-(2-hydroxy-5-substituted phenyl)-3-phenylpropylamines, intermediates for making hydroxytolterodine
WO2011141932A2 (en) 2010-05-11 2011-11-17 Intas Pharmaceuticals Limited Process for preparation of phenolic monoesters of hydroxymethyl phenols
IT1401451B1 (it) 2010-06-10 2013-07-26 Chemi Spa Nuovo processo di preparazione di 2-idrossi-4-fenil-3,4-diidro-2h-cromen-6-il-metanolo e (r)-2-[3-(diisopropilammino)-1-fenilpropil]-4-(idrossimetil)fenolo.
WO2011158257A1 (en) 2010-06-18 2011-12-22 Panacea Biotec Ltd Preparation process of fesoterodine and intermediates
IT1403094B1 (it) 2010-12-09 2013-10-04 Dipharma Francis Srl Procedimento per la preparazione di fesoterodina o un suo sale
WO2013113946A2 (en) 2012-05-04 2013-08-08 Crystal Pharma, S.A.U. Process for the preparation of optically active 3,3-diphenylpropylamines
WO2013188829A1 (en) 2012-06-14 2013-12-19 Ratiopharm Gmbh Desfesoterodine salts
ITMI20121232A1 (it) 2012-07-16 2014-01-17 Cambrex Profarmaco Milano Srl Procedimento per la preparazione di 2-(3-n,n-diisopropilamino-1-fenilpropil)-4-idrossimetil-fenolo e suoi derivati
CN103193747A (zh) * 2013-04-18 2013-07-10 中国药科大学 一种富马酸弗斯特罗定中间体的制备方法
WO2017137955A1 (en) 2016-02-14 2017-08-17 Celestis Pharmaceuticals Pvt. Ltd. Novel (r) and rac 3-(2-(allyloxy)-5-methylphenyl)-n,n-diisopropyl-3- phenylpropan-1-amine and its use for synthesis of (r) and rac-2-(3- (diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenol

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8800207D0 (sv) * 1988-01-22 1988-01-22 Kabivitrum Ab Nya aminer, deras anvendning och framstellning
SE9203318D0 (sv) * 1992-11-06 1992-11-06 Kabi Pharmacia Ab Novel 3,3-diphenylpropylamines, their use and preparation
KR20000057548A (ko) * 1996-12-13 2000-09-25 알프레드 엘. 미첼슨 광학적 전송물질 및 결합재
SE9701144D0 (sv) * 1997-03-27 1997-03-27 Pharmacia & Upjohn Ab Novel compounds, their use and preparation
JP3913329B2 (ja) * 1997-09-11 2007-05-09 株式会社クラレ （±）−クロマンカルボン酸の光学分割法
EP0957073A1 (en) * 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
DE19955190A1 (de) * 1999-11-16 2001-06-21 Sanol Arznei Schwarz Gmbh Stabile Salze neuartiger Derivate von 3,3-Diphenylpropylaminen

Also Published As

Publication number Publication date
NZ521265A (en) 2004-06-25
IL151595A0 (en) 2003-04-10
CZ20023665A3 (cs) 2003-02-12
HUP0204563A2 (en) 2003-05-28
ZA200207204B (en) 2003-05-23
JP2004503520A (ja) 2004-02-05
BR0111266A (pt) 2003-12-16
ES2290153T3 (es) 2008-02-16
CN1429197A (zh) 2003-07-09
PL360845A1 (en) 2004-09-20
SK142003A3 (en) 2003-04-01
DE50112793D1 (de) 2007-09-13
WO2001096279A1 (de) 2001-12-20
JP2007231024A (ja) 2007-09-13
AU2001269063B2 (en) 2005-03-24
IS6534A (is) 2002-08-30
EP1289929B1 (de) 2007-08-01
KR100580568B1 (ko) 2006-05-16
AU6906301A (en) 2001-12-24
HUP0204563A3 (en) 2004-12-28
DE10028443C1 (de) 2002-05-29
US20030212292A1 (en) 2003-11-13
NO20025967D0 (no) 2002-12-12
US6809214B2 (en) 2004-10-26
NO20025967L (no) 2002-12-12
CN1234679C (zh) 2006-01-04
HK1050518A1 (en) 2003-06-27
ATE368640T1 (de) 2007-08-15
CA2412047C (en) 2008-09-09
KR20020093870A (ko) 2002-12-16
IL151595A (en) 2007-03-08
JP4002180B2 (ja) 2007-10-31
EP1289929A1 (de) 2003-03-12
RU2270188C2 (ru) 2006-02-20
CA2412047A1 (en) 2001-12-20

Similar Documents

Publication Publication Date Title
MXPA02009643A (es) Sintesis acortada de derivados de 3,3-diarilpropilamina.
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
MXPA02012033A (es) Derivados de 2-aminocarbonil-9h-purina.
SE9904505D0 (sv) Novel compounds
BG105177A (en) Novel substituted pyrazole derivatives
ATE316083T1 (de) Adamantanderivate
MY127718A (en) Dolastatin 10 derivatives.
PL364598A1 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
YU56302A (sh) Derivati 8,8a-dihidro-indeno/1,2-d/taizola, koji su supstituisani u 8a-položaju,postupak za njihovu proizvodnju i njihova primena kod leka npr.kao anorektičnog sredstva
JO2493B1 (en) New phenyl azatidinone with improved physical properties and methods of preparation of drugs containing it and its uses
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
MY120683A (en) New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals.
MXPA05012679A (es) Nuevos derivados de imidazoles, su preparacion y su uso como medicamento.
UA66866C2 (uk) Синтез морфолінових похідних
IL135364A0 (en) Vitamin d derivatives, processes for the production thereof and for producing pharmaceutical compositions containing the same
AU2002218422A1 (en) New desloratadine salts, process for their synthesis and pharmaceutical compositions thereof
MXPA05014127A (es) Uso de derivados de biciclo[2.2.1]heptano para la preparacion de composiciones farmaceuticas neuroprotectoras.
HUP0401895A2 (hu) Paroxetin N-formil származékai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
CA2426221A1 (en) New neurokinin antagonists, processes for preparing them and pharmaceutical compositions containing these compounds
MXPA04001856A (es) Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos.
MXPA04001852A (es) Uso de sistemas indan-1-ol c2-sustituidas para la produccion de medicamentos para la profilaxis o tratamiento de obesidad.
MXPA03003466A (es) Derivados de piranosido.
DE50105067D1 (de) Synthesezwischenprodukte zur herstellung von vitamin d-derivaten
MY135855A (en) "pyrrolopyrimidinone derivatives, process of preparation and use"
MXPA04001846A (es) Indan-1-onas c2-substituidas y sus derivados, metodos para su produccion y su uso como medicamentos.

Legal Events

Date Code Title Description
FG Grant or registration